Top Markets
#1 MowCat MowCat +367.92%
#2 龙虾 (Lobster) 龙虾 (Lobster) +75.81%
#3 Cortex Cortex +31.86%
#4 DexNet DexNet +23.19%
#5 OpenEden OpenEden +19.35%
#6 Akedo Akedo +18.27%
#7 MarsCoin MarsCoin +17.92%
#8 Magma Finance Magma Finance +17.81%
#9 Pons Pons +14.45%
#10 MANTRA MANTRA +14.20%
Coin of the day
MowCat MowCat
Innstillinger
Språk
NORSK
Valuta
USD
Tema
Avalyn Pharma Inc. Common Stock Avalyn Pharma Inc. Common Stock

Avalyn Pharma Inc. Common Stock

AVLN
Rangering i aksjer #7327
Avalyn Pharma Inc. operates as a biopharmaceutical firm currently in its... Avalyn Pharma Inc. operates as a biopharmaceutical firm currently in its clinical development phase. The company's primary focus is on creating inhaled pharmaceutical products to manage rare lung conditions, including pulmonary fibrosis and various other interstitial lung diseases (ILDs). Richard Glenn Vincent, Mark W. Surber, and Michael J. Kamdar co-founded the enterprise on May 27, 2011, and its corporate headquarters are situated in Boston, Massachusetts.
Aksjekurs
$36.75
Sist synkronisert: 2026-08-27
Markedsverdi
$1.63B
Endring (1 dag)
-0.78%
Endring (1 år)
-
Land
US
Handel Avalyn Pharma Inc. Common Stock (AVLN)

Kategori

Healthcare
Utbytteavkastning for Avalyn Pharma Inc. Common Stock (AVLN)
Avalyn Pharma Inc. Common Stock (aksjesymbol: AVLN) sin utbytteavkastning (TTM) per 2026 er: 0
Gjennomsnittlig utbytteavkastning de siste 5 årene: 0.00%
Utbytteavkastning for Avalyn Pharma Inc. Common Stock (AVLN) fra 2026 til 2026
Utbytteavkastning ved slutten av hvert år (TTM)
År Utbytteavkastning Endre
Ikke nok data for de angitte datoene.
Utbytteavkastning (TTM) for lignende selskaper eller konkurrenter
Selskap Utbytteavkastning Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
3.12%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
0.00%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH